Generic Medications Can Keep OOP Costs Down for Neurological Conditions

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 30, 2024 -- Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a study published online Oct. 30 in Neurology.

Amanda V. Gusovsky, Ph.D., M.P.H., from the Wexner Medical Center at The Ohio State University in Columbus, and colleagues examined medical cost trends for five common neurologic conditions. Annual OOP and total medication costs were quantified for 186,144 patients with epilepsy; 54,676 with multiple sclerosis; 45,909 with Parkinson disease; 169,127 with peripheral neuropathy; and 60,861 with dementia/Alzheimer disease who were seen by a neurologist.

The researchers observed an increase in OOP costs for multiple sclerosis medications, by an average of 217 percent. Higher OOP costs were seen for branded epilepsy medications versus generics. In the years after generic introduction, the annual OOP costs of duloxetine, pregabalin, rasagiline, rivastigmine, and memantine decreased 48 to 80 percent.

"Branded neurologic medication costs continue to increase. Using generics remains a powerful strategy for affordable prescribing," the authors write. "Multiple sclerosis medication costs remain exceptionally high, pose a substantial financial burden, and demand policy solutions such as cost caps."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-31 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords